Top in hem/onc: Clotting risk in long COVID; insurance advice for physicians

A recent study showed that patients with long COVID had a greater risk for abnormal blood clotting.

Researchers said the findings suggest there is a potential role for antithrombotic therapy in the management of these patients. It was the top story in hematology/oncology last week.

The second top story covered the importance of property and casualty insurance to protect physicians’ personal and business assets.

Read these and more top stories in hematology/oncology below:

Individuals with long COVID may be at greater risk for abnormal blood clotting lymphoma

Individuals with long COVID may have a higher risk for abnormal blood clotting, especially those who have difficulties with basic exercise for more than 12 weeks after infection, according to a study published in Blood Advances. Read more.

Protect personal and business assets with property and casualty insurance

Few have as much need for asset protection as physicians. As high-income earners, physicians often have substantial financial assets and real property that needs to be removed from risks of loss due to liability, malpractice claims, worker complaints, cyberattacks, HIPAA violations and more. Read more.

‘Communication is key’ to reduce suicide risk after cancer diagnosis

Studies consistently have shown patients with cancer have a higher risk for suicide than the general public. Read more.

As proton beam therapy use for cancer increased, ‘so did the racial disparity in receipt’

Use of proton beam therapy increased significantly among patients with cancer in the U.S. between 2004 and 2018, but Black individuals had a lower likelihood of receiving the therapy than their white counterparts. Read more.

Study finds ‘substantial’ underrepresentation of Black patients in CAR-T clinical trials

Black patients appeared consistently underrepresented in pivotal clinical trials that led to FDA approval of several chimeric antigen receptor T-cell therapies, according to findings published in JAMA Network Open. Read more.